Atlas Corp. and Seaspan Corporation Announce Release of 2024 Sustainability Report, Highlighting Commitment to Environmental, Social, and Governance Excellence,www.prnewswire.com

by

Atlas Corp. and Seaspan Corporation Announce Release of 2024 Sustainability Report, Highlighting Commitment to Environmental, Social, and Governance Excellence NEW YORK, NY – July 1, 2025 – Atlas Corp. (NYSE: ATLS) and its leading global maritime asset owner and operator, Seaspan Corporation, are pleased to announce the release of their comprehensive 2024 Sustainability Report. This … Read more

Baidu Announces Management Changes,www.prnewswire.com

by

Baidu, a leading Chinese technology company, has announced a significant shift in its senior leadership, with a press release detailing management changes effective July 1, 2025. This announcement, published onprnewswire.com at 4:05 AM PST on July 1, 2025, signals a new chapter for the internet giant as it navigates an ever-evolving technological landscape. While the … Read more

Marine Collagen Market Poised for Significant Growth, Expected to Reach $2.32 Billion by 2032,PR Newswire Healthring

by

Here is an article based on the provided press release, written in a polite and informative tone: Marine Collagen Market Poised for Significant Growth, Expected to Reach $2.32 Billion by 2032 A recent report from Meticulous Research®, published by PR Newswire Healthring on June 30, 2025, projects substantial growth for the marine collagen market. The … Read more

Cymbiotika Earns Coveted 2025 Great Place To Work Certification™,PR Newswire Healthring

by

Cymbiotika Earns Coveted 2025 Great Place To Work Certification™ San Diego, CA – June 30, 2025 – Cymbiotika, a leading innovator in health and wellness, is proud to announce its recognition as a certified Great Place To Work® for 2025. This prestigious certification underscores Cymbiotika’s unwavering commitment to fostering a positive and thriving work environment … Read more

Nektar Therapeutics Announces Proposed Public Offering to Support Future Growth,PR Newswire Healthring

by

Here’s a detailed article about Nektar Therapeutics’ proposed public offering, presented in a polite tone: Nektar Therapeutics Announces Proposed Public Offering to Support Future Growth San Francisco, CA – June 30, 2025 – Nektar Therapeutics, a biopharmaceutical company dedicated to developing innovative medicines, has announced a significant development in its strategic financial planning. The company … Read more

Applications Open for the Next Cohort of N-SISS Fellows, Offering a Transformative Opportunity in Surgical Innovation,PR Newswire Healthring

by

Applications Open for the Next Cohort of N-SISS Fellows, Offering a Transformative Opportunity in Surgical Innovation [City, State] – [Date of publication, e.g., July 1, 2025] – Healthring, a leading voice in the health industry, announced today that applications are officially open for the next ten fellows to join the prestigious N-SISS (Novel Surgical Innovation … Read more

Brazil’s Central Bank Raises Interest Rates for Seventh Consecutive Meeting, Policy Rate Hits 15%,日本貿易振興機構

by

Brazil’s Central Bank Raises Interest Rates for Seventh Consecutive Meeting, Policy Rate Hits 15% Tokyo, Japan – June 30, 2025 – The Bank of Brazil (Banco Central do Brasil) has once again signaled its commitment to taming inflation by announcing its seventh consecutive interest rate hike, pushing the benchmark policy rate, known as the Selic … Read more

Neurocrine Biosciences Announces Initiation of Phase 1 Clinical Study Evaluating NBIP-01435, a Long-Acting Corticotropin-Releasing Factor Type 1 Receptor Antagonist,PR Newswire Healthring

by

Neurocrine Biosciences Announces Promising Initiation of Phase 1 Clinical Study for NBIP-01435 San Diego, CA – June 30, 2025 – Neurocrine Biosciences, Inc. (NASDAQ: NBIX), a leading neuroscience-focused biopharmaceutical company, has announced a significant milestone with the initiation of a Phase 1 clinical study for its novel compound, NBIP-01435. This investigational drug candidate is a … Read more

BerGenBio and Oncoinvent Poised to Merge, Ushering in a New Era for Radiopharmaceutical Cancer Therapies,PR Newswire Healthring

by

BerGenBio and Oncoinvent Poised to Merge, Ushering in a New Era for Radiopharmaceutical Cancer Therapies Bergen, Norway – June 30, 2025 – In a significant development for the field of oncology, BerGenBio ASA and Oncoinvent AS have announced a proposed merger that, upon completion, will unite two promising companies at the forefront of innovative cancer … Read more

Pleasanton, CA – June 30, 2025,PR Newswire Healthring

by

Saluda Medical Appoints Barry Regan as Chief Executive Officer Pleasanton, CA – June 30, 2025 – Saluda Medical, a pioneering company dedicated to advancing neuromodulation therapies, today announced the appointment of Barry Regan as its new Chief Executive Officer. Mr. Regan brings a wealth of experience in the medical device industry, with a proven track … Read more